Home Stock

Stock Research: Merck (USA)

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Merck (USA)

NYQ:MRK US58933Y1055
93
  • Value
    75
  • Growth
    26
  • Safety
    Safety
    94
  • Combined
    84
  • Sentiment
    63
  • 360° View
    360° View
    93
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Merck & Co., Inc. is a global healthcare company providing health solutions through prescription medicines, vaccines, and animal health products. It operates in the pharmaceutical and animal health industries. The company sells its products globally. In the last fiscal year, the company had a market cap of $204699 million, profits of $49470 million, revenue of $64168 million, and 75000 employees.

more

ANALYSIS: With an Obermatt 360° View of 93 (better than 93% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Merck (USA) are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Merck (USA). The consolidated Value Rank has an attractive rank of 75, which means that the share price of Merck (USA) is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 75% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 94. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 63. But the consolidated Growth Rank has a low rank of 26, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 74 of its competitors have better growth. ...read more

more
Strongest Rank Capital Growth
Weakest Rank Dividend Yield
Country USA
Industry Pharmaceuticals
Size XX-Large
Website merck.com
Index
Dow Jones
D.J. US Health Care
D.J. US Pharmaceutical
S&P 500
Merck (USA) stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
75 84 60 81
Growth
26 39 43 59
Safety
Safety
94 42 46 94
Sentiment
63 34 88 96
360° View
360° View
93 28 73 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
20 39 57 27
Opinions Change
61 15 50 83
Pro Holdings
n/a 86 96 96
Market Pulse
66 37 74 72
Sentiment
63 34 88 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
75 84 60 81
Growth
26 39 43 59
Safety Safety
94 42 46 94
Combined
84 47 44 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
52 32 24 36
Price vs. Earnings (P/E)
12 77 65 88
Price vs. Book (P/B)
28 32 10 12
Dividend Yield
100 96 89 94
Value
75 84 60 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
26 49 56 51
Profit Growth
96 56 10 62
Capital Growth
6 40 56 32
Stock Returns
48 27 59 73
Growth
26 39 43 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
29 31 45 34
Refinancing
84 10 23 95
Liquidity
87 94 82 89
Safety Safety
94 42 46 94

Similar Stocks

Discover high‑ranked alternatives to Merck (USA) and broaden your portfolio horizons.

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Resideo Technologies

NYQ:REZI
Country: USA
Industry: Building Products
Size: Large
Full Stock Analysis

Peabody Energy

NYQ:BTU
Country: USA
Industry: Coal & Consumable Fuels
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews